Biomarkers of atherosclerosis: clinical applications

Item

http://www.wikidata.org/entity/Q37307999

description

2008 nî lūn-bûn

@nan

2008年の論文

@ja

2008年学术文章

@wuu

2008年学术文章

@zh-cn

2008年学术文章

@zh-hans

2008年学术文章

@zh-my

2008年学术文章

@zh-sg

2008年學術文章

@yue

2008年學術文章

@zh

2008年學術文章

@zh-hant

name

Biomarkers of atherosclerosis: clinical applications

@en

Biomarkers of atherosclerosis: clinical applications.

@nl

type

Item

label

Biomarkers of atherosclerosis: clinical applications

@en

Biomarkers of atherosclerosis: clinical applications.

@nl

prefLabel

Biomarkers of atherosclerosis: clinical applications

@en

Biomarkers of atherosclerosis: clinical applications.

@nl

P1476

Biomarkers of atherosclerosis: clinical applications

@en

P2093

Todd M Brown

http://www.w3.org/2001/XMLSchema#string

P2860

Prediction of Coronary Heart Disease Using Risk Factor Categories

Markers of inflammation and cardiovascular disease: application to clinical and public health practice: A statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association

N-terminal fragment of the prohormone brain-type natriuretic peptide (NT-proBNP), cardiovascular events, and mortality in patients with stable coronary heart disease

Association of cystatin C with mortality, cardiovascular events, and incident heart failure among persons with coronary heart disease: data from the Heart and Soul Study

Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)

ACC/AHA 2007 Guidelines for the Management of Patients With Unstable Angina/Non–ST-Elevation Myocardial Infarction

Use of multiple biomarkers to improve the prediction of death from cardiovascular causes

Association between lipoprotein-associated phospholipase A2 and cardiovascular disease: a systematic review.

Rosuvastatin in the primary prevention of cardiovascular disease among patients with low levels of low-density lipoprotein cholesterol and elevated high-sensitivity C-reactive protein: rationale and design of the JUPITER trial.

Troponin I as a predictor of coronary heart disease and mortality in 70-year-old men: a community-based cohort study.

P2888

s11886-008-0078-1

P304

497-504

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S11886-008-0078-1

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Vera Bittner

P577

2008-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

23413866

http://www.w3.org/2001/XMLSchema#string

P698

18950561

http://www.w3.org/2001/XMLSchema#string

P921

atherosclerosis

biomarker

P932

2774886

http://www.w3.org/2001/XMLSchema#string